Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Myeloid, Acute 387Leukemia 339Hematologic Neoplasms 313Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma 142Leukemia, Myelogenous, Chronic, BCR-ABL Positive 140Neoplasms 115Myelodysplastic Syndromes 108Multiple Myeloma 98Lymphoma, Non-Hodgkin 95Hodgkin Disease 60Lymphoma, Large B-Cell, Diffuse 56Lymphoma, Follicular 56Congenital Abnormalities 52Lymphoma, Mantle-Cell 49Burkitt Lymphoma 48Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Chronic-Phase 45Myeloproliferative Disorders 42Leukemia, Myelomonocytic, Chronic 41Breast Neoplasms 41Leukemia, Hairy Cell 36Recurrence 35Lung Neoplasms 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Neoplasms, Plasma Cell 31Lymphoma, T-Cell, Cutaneous 31Lymphoma, Large-Cell, Immunoblastic 31Waldenstrom Macroglobulinemia 28

Interventions

rasburicase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hyperuricemia × Other hematologic neoplasm × Clear all
NCT00186940 2017-04-25

Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

St. Jude Children's Research Hospital

Completed
16 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Tumor Lysis Syndrome, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡